6 Followers on Owler
TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer...
Read moreTScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer...
Read more
Looking for similar companies to TScan?
TScan Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$13.3M
TScan's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 25.6M. Over the last four quarters, TScan's revenue has grown by 17.8%. Specifically, in Q3 2022's revenue was $3.4M; in Q2 2022, it was $4.1M; in Q1 2022, it was $3M; in Q4 2021, TScan's revenue was $2.9M.
TScan News
TScan Press Releases
TScan Headquarters
TScan Summary
ABOUT
Overview
TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer. TScan was founded in 2018. TScan's headquarters is located in Waltham, Massachusetts, USA 02451. TScan's CEO, Davi...CEO
TScan's CEO, David Southwell, currently has an approval rating of 83%. TScan's primary competitors are Geneos, PACT Pharma & Instil Bio.Website
tscan.comCompetitors
View 22 TScan competitors here.Acquisitions
There have been no acquisitions found related to TScanFunding
View TScan funding details.Investments
Recent investment data cannot be found related to TScanFrequently Asked Questions about TScan
When was TScan founded?
TScan was founded in 2018Who is TScan's CEO?
TScan's CEO is David SouthwellHow much revenue does TScan generate?
TScan generates $13.3M in revenueHow much funding does TScan have?
TScan has historically raised $320M in funding
Where is TScan's headquarters?
TScan's headquarters is in Waltham Massachusetts, USAHow many employees does TScan have?
TScan has 110 employeesWhat sector does TScan operate in?
TScan is in Biotechnology, PharmaceuticalsWho are TScan's competitors?
TScan's top competitors are Geneos, PACT Pharma, Instil Bio